Products / CNS APIs

CNS APIs

Inke develops and manufactures API ingredients for use in CNS therapies, as a subsidiary of Neuraxpharm,
a European leader in pharmaceutical products for the central nervous system (CNS)

API	Indication	Micronised / PSD	CEP	EU DMF	US DMF	JP DMF	KR DMF
Asenapine maleate^p	Schizophrenia and acute mania	•
Benserazide	Parkinson's disease
Eletriptan HBr^p	Migraine	•				•
Olanzapine^p	Schizophrenia, psychosis		•		•
Olanzapine pamoate	Schizophrenia, psychosis	•
Paliperidone palmitate	Schizophrenia, bipolar mania
Pipamparone	Schizophrenia
Quetiapine hemifumarate^p	Schizophrenia, psychosis		•			•	•
Risperidone^p	Schizophrenia, psychosis	•		•	•		•
Rizatriptan benzoate^p	Migraine	•	•		•
Tetrabenazine	Parkinson disease
Zolmitriptan^p	Migraine	•	•		•

DOWNLOAD INKE APIs PRODUCT LIST

P = Patent applications/granted patents owned by Neuraxpharm

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.